Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Ibuprofenamine Hydrochloride Topical Spray in Healthy Volunteers
ChiCTR-IIR-16008591Phase 4Recruiting
- Sponsor
- Beijing Hospital
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ibuprofenamine hydrochloride in osteoarthritis (OA), sponsored by Beijing Hospital. Primary endpoint: Safety and tolerability of escalating single and multiple topical doses of ibuprofenamine hydrochloride spray. Started May 2016; status: recruiting.
02
Drugs
ibuprofenamine hydrochloride
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR-IIR-16008591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-16008591.